Sveriges mest populära poddar

Veterinary Vertex

Innovations in Canine Cancer Treatment: Harnessing Immunotherapy

26 min • 3 december 2024

Send us a text

Can dogs benefit from the same revolutionary cancer treatments as humans? Join us as we explore the promising world of canine cancer immunotherapy with our distinguished guest, Dr. Tim Fan. Tim sheds light on breakthrough strategies like monoclonal antibodies, cancer vaccines, and adoptive cellular therapies, transforming how we manage cancer in our beloved pets. Drawing from his recent JAVMA article, he explains how these innovations leverage the immune system's power to fight cancer, offering hope for more effective treatments. Learn how advancements in veterinary medicine are extending pet lives, making the fight against geriatric diseases like cancer more crucial than ever.

Looking ahead, we focus on the future of immunotherapy in veterinary care, especially the potential of AI to personalize treatments by analyzing complex data like the tumor microenvironment. Tim's research, enriched by collaborations with clinical residents and PhD students, provides a unique perspective on setting realistic expectations for immunotherapy's effectiveness. We delve into the necessity of combination therapies to broaden the impact of these treatments, underscoring the importance of evolving strategies in veterinary oncology. This episode is a must-listen for pet owners, and anyone interested in the future of cancer treatment.

Open access article: https://doi.org/10.2460/javma.24.08.0532

INTERESTED IN SUBMITTING YOUR MANUSCRIPT TO JAVMA ® OR AJVR ® ?

JAVMA ® : https://avma.org/JAVMAAuthors

AJVR ® : https://avma.org/AJVRAuthors

FOLLOW US:

JAVMA ® :

Facebook: Journal of the American Veterinary Medical Association - JAVMA | Facebook

Instagram: JAVMA (@avma_javma) • Instagram photos and videos

Twitter: JAVMA (@AVMAJAVMA) / Twitter

AJVR ® :

Facebook: American Journal of Veterinary Research - AJVR | Facebook

Instagram: AJVR (@ajvroa) • Instagram photos and videos

Twitter: AJVR (@AJVROA) / Twitter

JAVMA ® and AJVR ® LinkedIn: https://linkedin.com/company/avma-journals

00:00 -00:00